Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_3
1
10%
Ph phase_1
2
20%
Ph phase_2
4
40%
Ph early_phase_1
1
10%
Ph phase_4
2
20%

Phase Distribution

3

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)
Other(2)

Detailed Status

Completed5
Terminated2
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
71.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (10.0%)
Phase 12 (20.0%)
Phase 24 (40.0%)
Phase 31 (10.0%)
Phase 42 (20.0%)

Trials by Status

not_yet_recruiting110%
completed550%
terminated220%
unknown220%

Recent Activity

0 active trials
Showing 5 of 10
not_yet_recruitingphase_2

A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients

NCT06907485
terminatedphase_3

Fluorescence Imaging of Carcinoma During Breast Conserving Surgery

NCT04815083
completedearly_phase_1

Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides

NCT03281811
completedphase_1

Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

NCT00978081
completedphase_4

Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis

NCT02409732
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06907485Phase 2

A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients

Not Yet Recruiting
NCT04815083Phase 3

Fluorescence Imaging of Carcinoma During Breast Conserving Surgery

Terminated
NCT03281811Early Phase 1

Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides

Completed
NCT00978081Phase 1

Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

Completed
NCT02409732Phase 4

Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis

Completed
NCT02647151Phase 4

Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel

Unknown
NCT00571558Phase 1

Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia

Terminated
NCT00747903Phase 2

Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer

Unknown
NCT00002963Phase 2

Photodynamic Therapy in Treating Patients With Skin Cancer

Completed
NCT00054171Phase 2

Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10